Citation Impact
Citing Papers
Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.
1988
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
2013 Standout
Use and Abuse of HOMA Modeling
2004 Standout
Obesity and insulin resistance in humans: A dose-response study
1990
Thiazolidinediones
2004 Standout
The acylation stimulating protein pathway: Clinical implications
1997
Intravenous Refeeding Blocks Growth Hormone (GH)-Provoked Rises in Serum Free Fatty Acids and Blunting of Somatotroph Response to GH-Releasing Hormone in Normal Men*
1989
Pathophysiology of Progressive Nephropathies
1998 Standout
Short and long term effects of antihypertensive therapy in the diabetic rat
1989
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Increased de novo Lipogenesis and Delayed Conversion of Large VLDL into Intermediate Density Lipoprotein Particles Contribute to Hyperlipidemia in Glycogen Storage Disease Type 1a
2008
Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
2007 Standout
Weight loss in obese men by caloric restriction and high‐dose diazoxide–mediated insulin suppression
2008
International table of glycemic index and glycemic load values: 2002,
2002 Standout
Interactions Between Glucose and FFA Metabolism in Man
1996
Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.
1989 Standout
7 Insulin action and substrate competition
1993
Effects of Postmenopausal Estrogen Replacement on the Concentrations and Metabolism of Plasma Lipoproteins
1991
Glucose uptake and insulin action in human adipose tissue—influence of BMI, anatomical depot and body fat distribution
2002
Glucose, insulin concentrations and obesity in childhood and adolescence as predictors of NIDDM
1994
Association of ACE gene polymorphism and diabetic nephropathy?
1995
The Role of Free Fatty Acid Metabolism in the Pathogenesis of Insulin Resistance in Obesity and Noninsulin-Dependent Diabetes Mellitus*
1991
U.K. Prospective Diabetes Study XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM
1995 StandoutNobel
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Williams–Beuren Syndrome
2010 Standout
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
2005 Standout
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance
1999
Diabetes and Atherosclerosis
2002 Standout
Endocrine Aspects of Obesity
1989
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
Global and societal implications of the diabetes epidemic
2001 StandoutNature
Adipocyte functions are modulated by cell size change: potential involvement of an integrin/ERK signalling pathway
2003
The Effects of Treatment with Recombinant Human Growth Hormone on Body Composition and Metabolism in Adults with Growth Hormone Deficiency
1989 Standout
Myeloperoxidase binds to low‐density lipoprotein: potential implications for atherosclerosis
2000
Lipoprotein lipase modulates net secretory output of apolipoprotein B in vitro. A possible pathophysiologic explanation for familial combined hyperlipidemia.
1991
Lipotoxicity, overnutrition and energy metabolism in aging
2006
Cholesterol, a Cell Size-dependent Signal That Regulates Glucose Metabolism and Gene Expression in Adipocytes
2001
Mechanisms of insulin resistance related to white, beige, and brown adipocytes
2020
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
SEQUENTIAL CHANGES IN SERUM INSULIN CONCENTRATION DURING DEVELOPMENT OF NON-INSULIN-DEPENDENT DIABETES
1989
Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.
1993
The RAAS in the pathogenesis and treatment of diabetic nephropathy
2010
A newly discovered apolipoprotein B-containing high-density lipoprotein produced by human hepatoma cells
1987
Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia
2001 Standout
Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM
1997
Insulin sensitivity in women at risk of coronary heart disease and the effect of a low glycemic diet
1998
Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids
1995 Standout
Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in Type 1 (insulin-dependent) diabetes mellitus
1987
Apolipoprotein B-100 kinetics in visceral obesity: Associations with plasma apolipoprotein C-III concentration
2002
The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
1993 Standout
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
Metabolic and molecular basis of insulin resistance
2003
The role of lipid peroxidation and antioxidants in oxidative modification of LDL
1992 Standout
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview
2000 Standout
Influence of body fat distribution on free fatty acid metabolism in obesity.
1989
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Diabetes mellitus and hypertension.
1992
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
2009 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Hypertriglyceridemic HyperapoB: The Unappreciated Atherogenic Dyslipoproteinemia in Type 2 Diabetes Mellitus
2001
Characterization of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic intima.
1988
Brown Adipose Tissue: Function and Physiological Significance
2004 Standout
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
2002 Standout
Control of lipolysis and its relevance to development of obesity in man
1988
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Regulation of Lipolysis in Adipocytes
2007
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
1995 Standout
Understanding “insulin resistance”: Both glucose resistance and insulin resistance are required to model human diabetes
1991
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
2000 Standout
Diabetes mellitus in the pima indians: Incidence, risk factors and pathogenesis
1990
Effect of phlorizin on SGLT2 expression in the kidney of diabetic rats.
2010
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Westernisation, insulin resistance and diabetes in Australian Aborigines
1991
Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
1997 Standout
Metabolic Dysregulation and Adipose Tissue Fibrosis: Role of Collagen VI
2008 Standout
Mechanisms of Diabetic Complications
2013 Standout
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Interactions Between Glucose and FFA Metabolism in Man
1996
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
The Metabolic Syndrome
2008 Standout
Role of Insulin Resistance in Human Disease
1988 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity
1992
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
2001 Standout
In vivo regulation of lipolysis in humans.
1994
Selective Retention of VLDL, IDL, and LDL in the Arterial Intima of Genetically Hyperlipidemic Rabbits In Vivo
1995
Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance
2003 StandoutScience
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
1999 Standout
Angiotensin Blockade Improves Cardiac and Renal Complications of Type II Diabetic Rats
1997 StandoutNobel
Works of David Brady being referenced
In vitro insensitivity of glucose transport and antilipolysis to insulin due to receptor and postreceptor abnormalities in obese Pima Indians with normal glucose tolerance
1984
Exchangeable sodium and renin in hypertensive diabetic patients with and without nephropathy.
1985
Decreased Activation Rate of Insulin-Stimulated Glucose Transport in Adipocytes From Obese Subjects
1989
Isopropanol precipitation method for the determination of apolipoprotein B specific activity and plasma concentrations during metabolic studies of very low density lipoprotein and low density lipoprotein apolipoprotein B.
1983
Blood pressure may be sodium-dependent in diabetic patients without overt nephropathy
1985
The Antilipolytic Action of Insulin in Obese Subjects with Resistance to Its Glucoregulatory Action*
1984